Michael Leek
Founder bij TC BIOPHARM (HOLDINGS) PLC
Profiel
Michael Leek founded TC Biopharm Ltd.
in 2014, where he is working as Chief Executive Officer from 2014 and TC Biopharm (Holdings) Plc in 2013, where he is working as Chief Technology Officer from 2023.
Dr. Leek also founded TCB Newco Ltd., where he is working as Chairman & Chief Executive Officer.
Dr. Leek also formerly worked at Intercytex Ltd., as Vice President-Operations from 2000 to 2006.
Dr. Leek received his doctorate degree from the University of Leeds.
Actieve functies van Michael Leek
| Bedrijven | Functie | Begin |
|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Founder | 01-01-2013 |
TC Biopharm Ltd.
 TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Chief Executive Officer | 01-01-2014 |
TCB Newco Ltd.
 TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Chief Executive Officer | - |
Eerdere bekende functies van Michael Leek
| Bedrijven | Functie | Einde |
|---|---|---|
Intercytex Ltd.
 Intercytex Ltd. Pharmaceuticals: MajorHealth Technology The company is developing cell-based treatments for skin and hair regeneration. Its TrichoCyte product candidate is injected just beneath the scalp to encourage new hair follicles to form. Another product candidate, ProtoDerm, could treat diabetic ulcers and other chronic dermal wounds. | Chief Operating Officer | 03-02-2006 |
Opleiding van Michael Leek
| University of Leeds | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Intercytex Ltd.
Intercytex Ltd. Pharmaceuticals: MajorHealth Technology The company is developing cell-based treatments for skin and hair regeneration. Its TrichoCyte product candidate is injected just beneath the scalp to encourage new hair follicles to form. Another product candidate, ProtoDerm, could treat diabetic ulcers and other chronic dermal wounds. | Health Technology |
TC Biopharm Ltd.
TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
